JAK2 and esophageal squamous cell carcinoma: These findings imply that WDFY3‐AS2 functions as a key regulator in cell proliferation and invasion by targeting miR‐2355‐5p/SOCS2/JAK2/Stat5 signalling pathway in ESCC.